UMN Pharma Inc. | |
Stock Exchange | Tokyo Stock Exchange |
EPS |
JPY52.29 |
Market Cap |
JPY4.83 B |
Shares Outstanding |
15.3 M |
Public Float |
11.73 M |
Address |
4-2-3 Gosyonoyumoto Akita Akita 010 Japan |
Employees | - |
Website | http://www.umnpharma.com |
Updated | 07/08/2019 |
UMN Pharma, Inc. engages in the development, manufacture, and sale of biopharmaceuticals. It develops vaccines targeting influenza, norovirus, and rotavirus. The company was founded by Masahiro Michishita and Shuichi Kanazashi on April 20, 2004 and is headquartered in Akita, Japan. |